Insider · CIK 0001503685

Ollier Michele

Reports to the SEC for 2 companies · GENEVA, V8

sec.gov

Transactions

Companies

Filings

CIK

0001503685

Forms 4 and 5

Insider transactions

22 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2016-12-12	NERVMinerva Neurosciences, Inc.X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	+203K sh	$5.77	+$1.17M	4,690,906
2016-12-12	NERVMinerva Neurosciences, Inc. · Warrant SharesX Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	−203K sh	—	—	0
2016-08-10	NERVMinerva Neurosciences, Inc.S Sale	Director, 10% Owner	SSale	−1M sh	$10.00	−$10M	4,488,272
2015-03-18	NERVMinerva Neurosciences, Inc.P Purchase	Director, 10% Owner	PPurchase	+203K sh	$4.81	+$975K	5,488,272
2015-03-18	NERVMinerva Neurosciences, Inc. · Warrant SharesP Purchase	Director, 10% Owner	PPurchase	+203K sh	$0.13	+$25.3K	202,634
2014-07-07	NERVMinerva Neurosciences, Inc.C Conversion	Director, 10% Owner	CConversion	+114K sh	$6.00	+$684K	3,602,883
2014-07-07	NERVMinerva Neurosciences, Inc.C Conversion	Director, 10% Owner	CConversion	+61.9K sh	$6.00	+$372K	3,664,805
2014-07-07	NERVMinerva Neurosciences, Inc.P Purchase	Director, 10% Owner	PPurchase	+1.29M sh	$6.00	+$7.73M	4,952,305
2014-07-07	NERVMinerva Neurosciences, Inc.P Purchase	Director, 10% Owner	PPurchase	+333K sh	$6.00	+$2M	5,285,638
2014-07-07	NERVMinerva Neurosciences, Inc. · Convertible Promissory NoteC Conversion	Director, 10% Owner	CConversion	−114K sh	$6.00	−$684K	0
2014-07-07	NERVMinerva Neurosciences, Inc. · Convertible Promissory NoteC Conversion	Director, 10% Owner	CConversion	−61.9K sh	$6.00	−$372K	0
2011-07-29	Aegerion Pharmaceuticals, Inc.S Sale	Director, 10% Owner	SSale	−36.8K sh	$14.61	−$537K	2,131,827
2011-06-29	Aegerion Pharmaceuticals, Inc.S Sale	Director, 10% Owner	SSale	−878K sh	$14.61	−$12.8M	2,168,435
2011-06-01	Aegerion Pharmaceuticals, Inc.Stock Option (right to buy)A Award	Director, 10% Owner	AAward	−9,988 sh	—	—	9,988
2010-10-27	Aegerion Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+1.37M sh	—	—	1,371,518
2010-10-27	Aegerion Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+478K sh	—	—	1,849,241
2010-10-27	Aegerion Pharmaceuticals, Inc.C Conversion	Director, 10% Owner	CConversion	+881K sh	$7.60	+$6.7M	2,730,369
2010-10-27	Aegerion Pharmaceuticals, Inc.P Purchase	Director, 10% Owner	PPurchase	+316K sh	$9.50	+$3M	3,046,158
2010-10-27	Aegerion Pharmaceuticals, Inc.Series A Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−3.53M sh	—	—	0
2010-10-27	Aegerion Pharmaceuticals, Inc.Series B Convertible Preferred StockC Conversion	Director, 10% Owner	CConversion	−783K sh	—	—	0
2010-10-27	Aegerion Pharmaceuticals, Inc.Senior Subordinated Convertible Promissory NotesC Conversion	Director, 10% Owner	CConversion	—	—	—	—
2010-10-21	Aegerion Pharmaceuticals, Inc.Senior Subordinated Convertible Promissory NotesA Award	Director, 10% Owner	AAward	—	—	—	—

Recent filings

Accepted (ET)
Dec 144
Minerva Neurosciences, Inc.0001140361-16-089642
SEC(opens sec.gov)
Aug 124
Minerva Neurosciences, Inc.0001140361-16-076136
SEC(opens sec.gov)
Mar 204
Minerva Neurosciences, Inc.0001140361-15-012779
SEC(opens sec.gov)
Jul 94
Minerva Neurosciences, Inc.0001104659-14-050852
SEC(opens sec.gov)
Aug 24
Ollier Michele0000904454-11-000417
SEC(opens sec.gov)
Jul 14
Ollier Michele0000904454-11-000319
SEC(opens sec.gov)
Jun 34
Ollier Michele0001181431-11-034527
SEC(opens sec.gov)
Oct 274
Ollier Michele0001181431-10-052250
SEC(opens sec.gov)

Companies

Address

C/O INDEX VENTURES 2 RUE DE JARGONNANT

GENEVA, V8, 1207